During the past decade, Medstar Health Research Institute conducted 69 clinical trials. In the 10-year time frame, 69 clinical trials started and 32 clinical trials were completed, i.e. on average, 46.4% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 23 clinical trials were completed. i.e. 92% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medstar Health Research Institute" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Abbott Medical Devices" with 7 trials sponsored, "AstraZeneca" with 5 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored and "C. R. Bard" with 4 trials sponsored. Other sponsors include 74 different institutions and companies that sponsored additional 68 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medstar Health Research Institute" #1 collaborator was "Eli Lilly and Company" with 5 trials as a collaborator, "Medstar Health Research Institute" with 4 trials as a collaborator, "Medpace, Inc." with 3 trials as a collaborator, "ARMO BioSciences" with 2 trials as a collaborator and "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "Medstar Health Research Institute" are "Heart Failure" (10 trials), "Type 2 Diabetes" (8 trials), "Diabetes Mellitus, Type 2" (6 trials), "Type 2 Diabetes Mellitus" (5 trials) and "Diabetes" (4 trials). Many other conditions were trialed in "Medstar Health Research Institute" in a lesser frequency.

Most popular intervention types in "Medstar Health Research Institute" are "Drug" (54 trials), "Device" (43 trials), "Other" (11 trials), "Biological" (6 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "placebo" (4 trials), "AC2993" (3 trials), "Empagliflozin" (3 trials) and "Tirzepatide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Medstar Health Research Institute" are 104 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Medstar Health Research Institute". undefined are not yet recruiting, 15 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 58 completed trials in Medstar Health Research Institute, 2 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Medstar Health Research Institute, 4 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 28 trials that are defined as “Not Applicable".

Medstar Health Research Institute has several departments that took part in Clinical trials: "Washington Hospital Center Cardiovascular Research Institute" - 6 trials